Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery.
Lova L SunDavid ShimunovErik X TanSamuel Swisher-McclureAlexander LinJohn N LukensDevraj BasuAra A ChalianSteven B CannadyJason G NewmanKarthik RajasekaranBert W O'MalleyChristopher H RassekhGregory S WeinsteinLaurie A LoevnerCharu AggarwalAditi SinghRoger B CohenJoshua M BaumlRobert M BrodyPublished in: Head & neck (2021)
Patients with HPV + OPSCC who underwent TORS-TMT had excellent survival and low rates of toxicity and feeding tube dependence. These outcomes compare favorably to historical cohorts treated with definitive chemoradiotherapy.
Keyphrases
- squamous cell
- locally advanced
- endothelial cells
- oxidative stress
- free survival
- rectal cancer
- papillary thyroid
- high grade
- induced pluripotent stem cells
- squamous cell carcinoma
- metabolic syndrome
- type diabetes
- adipose tissue
- newly diagnosed
- replacement therapy
- muscle invasive bladder cancer
- weight loss
- smoking cessation